COOKIE POLICY  Close

Fidelity uses cookies to provide you with the best possible online experience. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on our site. However, you can change the cookie settings and view our cookie policy at any time.

The Fidelity difference

Fidelity is an active fund manager that focuses on bottom up global research. With one of the largest buy side research teams in the world, we have a unique ability to identify investment themes and ideas across different market cycles.

Foresight

We have a team of more than 400 investment professionals connecting ideas across asset classes, sectors and regions. Insights are shared in real time across the team to identify patterns and highlight investment ideas, so we can stay ahead of the game.

 

Further

We attend over 15,000 company meetings a year. We conduct bespoke research, survey and analysis. We believe that by going further we gain better insights and knowledge, to make better investment decisions for you. 

 

Future

Privately owned for half a century, Fidelity is an independent company and investment is our only business. We think generationally and we're driven by the needs of our clients. 

 

Why Fidelity?

Latest investment insights

After the selloff: What's next for Chinese equities?

After the selloff: What's next for Chinese equities?

A spate of regulatory actions across several sectors in China reached a recent crescendo that rattled markets and sent shares tumbling. But some of this selling appears overdone, creating opportunities for investors where long-term growth remains intact and policy impact is neutral - or positive.

30 July 2021 | Paras Anand
Asian equities
Daily market review

Daily market review

US shares mixed; Europe up on M&A, Asia higher
02 August 2021 | Anne D Picker Econoday
Daily market review
China's evolving regulatory and policy landscape

China's evolving regulatory and policy landscape

In our recent client call, CIO Paras Anand took investors through the spate of regulatory actions across several sectors in China which saw Chinese equities plunge. Read the summary of the call where we discuss the policy impacts.

30 July 2021 | Paras Anand
Asian equities
The Delta variant: UK a test-case for re-opening and vaccine impact?

The Delta variant: UK a test-case for re-opening and vaccine impact?

In recent weeks, market sentiment has stuttered as investors evaluate the cases of the Delta variant and the effectiveness of vaccines. The world is watching closely as the UK re-opens to pre-pandemic levels. Will high vaccination rates impact hospitalisations and set the blueprint for other economies?

28 July 2021 | Fidelity International
Global economics
Timing the market

Timing the market

You might reasonably think that investors are worrying about two contradictory things at the moment. Last week the concern seemed to be too much inflation; this week it's the likelihood of too little growth as the Delta variant takes hold. On the face of it, that makes no sense. They can’t both be a problem at the same time, can they?

27 July 2021 | Tom Stevenson
Global economics
View more insights

Want more insights like this?

Get our free, monthly e-newsletter bringing you valuable insights, opinion and education.

Subscribe 

 

Explore all of Fidelity’s funds

See for yourself what drives our portfolio managers' thinking, and how our funds have performed since inception.

Or see all Fidelity funds